PRGO
Perrigo Company plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IE
$14.92
+4.56%Margins
Gross margin
33.3%
EBITDA margin
-29.6%
EBIT margin
5.2%
Net margin
-41.9%
FCF margin
4.2%
-69.0%
Return on equity
-22.8%
Return on assets
3.7%
Return on invested capital
0.53x
Asset turnover
$251.8M
Cash from operations
$2.88
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026